New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
XLV

State Street Health Care Select Sector SPDR ETF

The XLV Exchange Traded Fund (ETF) is provided by State Street Investment Management. It is built to track an index: S&P Health Care Select Sector Index. The XLV ETF provides physical exposure, so by buying it you actually own parts of all the 59 underlying holdings. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$162.57
+$1.1 (+0.70%) yesterday
1:30 PM 07/24/26 Closed
1D price range
$161.58$163.25
52W price range
$128.99$164.50
YTD Perf.
+3.84%
YTD Flows
Annualized volatility
Fund AuM
€36.65B
Share class AuM
€36.65B
TTM Yield
Tracking Error
Tracking Difference
ISIN
US81369Y2090
TER
0.08%
Inception date
12/16/1998
Replication method
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Jul 22, 2026
-5%0%5%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
97.73%
Consumer Non-Cyclicals
2.31%
Latest XLV news

No content available for this fund

FAQ about XLV

XLV is a Passive ETF. This ETF provides exposure to Large Cap US Health Care Equities.
XLV tracks the S&P Health Care Select Sector Total Return Index - USD, through a full replication replication method.
XLV carries a total expense ratio (TER) of 0.08%, indicating the annual cost for holding the fund.
XLV was introduced to the market on December 16, 1998. It trades on United States
State Street Health Care Select Sector SPDR ETF, XLV, is provided by State Street Investment Management. Learn more about State Street Investment Management here.
XLV oversees €36.65B in assets as of July 22, 2026.
XLV follows a distributing dividend policy, meaning it pays out income to investors. As of July 22, 2026, its 12-month trailing yield was 1.59%.
As of June 30, 2026, XLV has significant geographic allocations in USA and Ireland.
As of June 30, 2026, XLV focuses largely on Healthcare and Consumer Non-Cyclicals.
As of June 30, 2026, XLV holds 59 positions in its portfolio, with 72.82% of assets concentrated in its top 15 holdings.
As of June 30, 2026, XLV top three holdings include Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..
The base currency of XLV is USD.
Data as of 06/30/26
Eli Lilly & Co.
16.57%
Johnson & Johnson
10.68%
AbbVie, Inc.
7.76%
UnitedHealth Group, Inc.
6.59%
Merck & Co., Inc.
5.54%
Amgen, Inc.
3.41%
Thermo Fisher Scientific, Inc.
3.25%
Abbott Laboratories
2.76%
Gilead Sciences, Inc.
2.74%
Intuitive Surgical, Inc.
2.46%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight